Information Bias in Electronic Health Records and Administrative Claims Data: A Targeted Review of the Recent Literature
- 21 October 2025
- journal article
- review article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 119 (2) , 362-367
Abstract
Randomized clinical trials represent the primary source of evidence for regulatory and health technology assessment (HTA) decision making; however, the integration of real‐world evidence (RWE) has increased in recent years. Despite its utility, RWE is often threatened by information bias, and the literature addressing measurement error in RWE remains underdeveloped. To address this gap, we conducted a targeted literature review to identify and synthesize mitigation measures for information bias in RWE generation among studies using electronic health records (EHRs) and administrative claims data. Our review covered articles published between January 2019 and May 2024 and included real‐world data (RWD) investigations with a focus on information bias case studies or review articles; to increase the utility of our results, the Food and Drug Administration’s guidance on assessing EHRs and medical claims data was also incorporated. Data elements were extracted and categorized to produce a comprehensive information bias mitigation framework. In total, 38 articles and guidance documents were included, primarily focusing on studies conducted in the United States ( n = 25) as well as studies using EHR data ( n = 31). Findings were synthesized into 15 general recommendations: six targeting study design, four addressing study variables, and five focused on statistical analyses. Prominent themes included validation, data linkage, and quantitative bias analysis. Overall, our findings underscore the diversity and complexity of the information bias in RWD literature. Our resulting framework offers practical recommendations and complements prior work, providing a foundation for future efforts to enhance the validity of RWE in regulatory/HTA decision making.Keywords
This publication has 19 references indexed in Scilit:
- Use of quantitative bias analysis to evaluate single‐arm trials with real‐world data external controlsPharmacoepidemiology and Drug Safety, 2024
- Use of Immunization Information Systems in Ascertainment of COVID-19 Vaccinations for Claims-Based Vaccine Safety and Effectiveness StudiesJAMA Network Open, 2023
- Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learnedPharmacoepidemiology and Drug Safety, 2023
- Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studiesPharmacoepidemiology and Drug Safety, 2022
- The Role of Real‐World Evidence in FDA‐Approved New Drug and Biologics License ApplicationsClinical Pharmacology & Therapeutics, 2021
- Prevalence of Avoidable and Bias‐Inflicting Methodological Pitfalls in Real‐World Studies of Medication Safety and EffectivenessClinical Pharmacology & Therapeutics, 2021
- Characterizing bias due to differential exposure ascertainment in electronic health record dataHealth Services and Outcomes Research Methodology, 2021
- Classification of drug use patternsPharmacology Research & Perspectives, 2020
- Measurement Error and Misclassification in Electronic Medical Records: Methods to Mitigate BiasCurrent Epidemiology Reports, 2018
- Identifying Patients With High Data Completeness to Improve Validity of Comparative Effectiveness Research in Electronic Health Records DataClinical Pharmacology & Therapeutics, 2017